Clinical trial · Interventional
Evaluating Quality and Cost of (Partial) Oncological Home-Hospitalization
A Single-center, Open Randomized Controlled Clinical Trial to Evaluate the Quality and Cost of (Partial) Oncological Home-hospitalization Compared to Standard Ambulatory Hospital Care
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Oncological home-hospitalization might be a patient-centred, cost-effective approach to deal wiht the current challenges in cancer healthcare. The primary aim of this clinical trial is to evaluate patient-reported quality of life of patients receiving (partial) oncological home-hospitalization and to compare this outcome with patients receiving standard ambulatory hospital care. Secondary endpoints that will be evaluated and compared between both randomized groups are: Quality of life related endpoints (i.e. distress, depression \& anxiety and general health-related quality of life); Costs; Safety; patients' reported Satisfaction \& Preferences and Efficiency for the hospital day care unit.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| (partial) oncological home-hospitalization | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention
- description
- (partial) oncological home-hospitalization
- interventionNames
- Procedure: (partial) oncological home-hospitalization
- type
- NO_INTERVENTION
- label
- Control
- description
- standard oncological ambulatory hospital care
Primary outcomes (2)
- measure
- Change in Patient-reported Quality of Life - Cancer specific
- timeFrame
- Inquiry at baseline, 4 weeks, 8 weeks and 12 weeks
- description
- Evaluation of the change of patient-reported quality of life for both study arms using FACT-G (Functional Assessment of Cancer Therapy - General) questionnaire.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Starting new oncological treatment at the outpatient hospital * ECOG ≤ 2 * Living within 30 minutes of drive from the hospital Exclusion Criteria: * Important comorbidity (ECOG \> 2) * Life expectancy \< 6 months * Simultaneous treatment with radiotherapy * Taking part in clinical trial with any Investigational Medicinal Product * Language barriers or communication difficulties * Problematic venous access
References
Publications (0)
Data not yet available